Technology | May 15, 2014

Mobile App Provides Life-Saving Assistance For Cardiac Patients

CathMaps+ debuts in Boston at AARP's Health [email protected]+ Tech Expo

CathMaps+ App Cath Lab Patient Engagement Mobile Devices

May 15, 2014 — CathMaps demonstrated how mobile technology can provide emergency assistance and peace of mind to millions of Americans at risk for a cardiac event. The AARP Health [email protected]+ Tech Expo showcases the latest in digital health technology designed to improve quality of life. The event is part of AARP's [email protected]+ National Event in Boston, May 8-10.

CathMaps+ is the world's first mobile application for people with elevated risk of a cardiac incident — particularly those who have a history of cardiac issues — that integrates critical health history and medical records with an interactive map of catheterization facilities (cath labs) throughout the world. The app is also HIPPA compliant.

"With the levels of heart disease on the rise in the U.S., the medical community must remain vigilant in our efforts to provide patients with tools and information that can help improve the quality of their lives," says Jack Stroh, an interventional cardiologist at Robert Wood Johnson University Hospital and St. Peter's University Hospital in New Jersey, and advisor to CathMaps+.

Approximately 715,000 Americans have a heart attack each year, according to the Centers for Disease Control. Nearly 30 percent of those have already suffered a heart attach. The CathMaps+ app ensures that patients quickly locate and are directed to a medical facility with a catheterization lab — wherever they may be traveling. They can securely access and share their medical history with the lab staff, saving critical time in treatment. They can also give permission for their information to be shared with loved ones, caregivers or emergency professionals.

"As a life or death condition, the idea of suffering a repeat incident is an almost constant concern. This app offsets patient anxiety, giving them peace of mind as they go about their daily lives," says Danny Oberman, founder and CEO of CathMaps+. "We see this as a valuable tool for cardiologist and the medical community as well. The AARP Health [email protected]+ Tech Expo is the perfect event to debut the app in the U.S."

Oberman founded CathMaps+ following his own cardiac incident in 2013. He combined his experience of living with an elevated risk of heart attack with his technology expertise to create a tool that is easy to use and functional in an emergency, while alleviating anxiety for cardiac patients.

CathMaps+, an Israeli-based technology company, is owned by Kickstart LLC, and is available for most Android and iOS users. The app is available in English and Spanish, with additional languages releases throughout 2014. It may be purchased from the App Store and Google Play.

For more information:

Related Content

bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system


Feature | Stents Bioresorbable| October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular S
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices| October 20, 2016
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug...
recall, alligator retrieval device, X-Celerator hydrophilic guidewire, UltraFlow flow directed micro catheters, Marathon flow directed micro catheters
News | Cath Lab| October 18, 2016
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline...
Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
3-D bioprinting, 3-D printing, printed organs, 3D bioprinting

3-D printed vessel made from living cells implanted in an animal to test feasibility of using such structures clinically. Blood vessels are a stepping stone to the creation of more complex 3-D printed organs made from biomaterials. Image from the South Carolina Project for Organ Biofabrication.


Feature | 3-D Printing| October 13, 2016 | Dave Fornell
The U.S. Food and Drug Administration (FDA) changed its rules concerning custom medical devices Oct.
Shockwave lithoplasty system, VIVA 16, Vascular Interventioanl Advances, VIA Physicians, late-breaking endovascular clinical trial results
News | Cath Lab| October 12, 2016
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical...
Terumo Finecross, guidewires, guide wires, guidewires 101, basics of guidewire technology

An illustration of Terumo's Finecross guidewire crossing a tight lesion. 

Feature | Guidewires| October 12, 2016 | Dave Fornell
While guidewires are a key tool used by
Medtronic, FDA clearance, TrailBlazer peripheral angled support catheter, PAD, peripheral artery disease
Technology | Peripheral Arterial Disease (PAD)| October 12, 2016
Medtronic plc announced recently that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer angled...
Overlay Init